Benzinga
Benzinga
Benzinga
giovedì, settembre 24

Tenet Healthcare Corp

THCNYSE
Trade with Public
Trade with Public
$256.44
-5.62-2.14%
In chiusura: Sep 23, 5:00 PM EST
$256.44
N/A
Post-mercato: 6:32 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Tenet Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tenet Healthcare (THC).

Price Target Range — 9 Quarters

Analyst Consensus — 20 Analysts

18Buy
2Hold
Consensus RatingOverweight# Analysts20Avg. Consensus PT$253Upside to Avg. PT-1.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Sep 23, 2026BMO CapitalSean DodgeInitiateMarket Perform$265
Sep 18, 2026Leerink PartnersWhit MayoMaintainedOutperform$309
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BMO Capital Initiates Coverage On Tenet Healthcare with Market Perform Rating, Announces Price Target of $265

BMO Capital analyst Sean Dodge initiates coverage on Tenet Healthcare (NYSE:THC) with a Market Perform rating and announces Price Target of $265.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $281

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $231 to $281.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $290

Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $270 to $290.
Benzinga Newsdesk

Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on top names. For a complete view, see analyst ratings page. See how others view these stocks.
Avi Kapoor

PRO
Baird Maintains Neutral on Tenet Healthcare, Raises Price Target to $280

Baird analyst Michael Ha maintains Tenet Healthcare (NYSE:THC) with a Neutral and raises the price target from $210 to $280.
Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $283

Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $242 to $283.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved